Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

UNITED STATES: Pfizer Halts Late-Stage Study into New Lyrica Use




 

Associated Press (05.04.12) - Monday, May 07, 2012

Pfizer said Friday it has stopped a late-stage study of its drug Lyrica as a potential treatment for HIV-related nerve pain. In the United States, Lyrica already is approved to treat nerve pain from diabetes, pain following shingles, fibromyalgia, and some seizures in adults with epilepsy. Pfizer has been studying Lyrica's potential use for HIV neuropathy, a condition involving nerve damage marked by burning pain that typically begins in the feet. However, an early analysis of study data found that pain improvements in treated patients were almost identical to those who received a placebo. The study did not raise any safety concerns; Pfizer plans further analysis of the results.



 


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in May 7, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.